Hepatitis B screening: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
High risk groups, such as : persons born in high or intermediate [[endemic]] areas; United States– born persons not [[vaccinated]] as infants whose parents were born in regions with high [[HBV]] endemicity; persons needing [[immunosuppressive therapy]]; patients with history of [[IV]] drugs history; among others should be tested for [[HBV infection]].
High risk groups, such as : persons born in high or intermediate [[endemic]] areas; United States– born persons not [[vaccinated]] as infants whose parents were born in regions with high [[HBV]] endemicity; persons needing [[immunosuppressive therapy]]; patients with history of [[IV]] drugs history; among others, should be tested for [[HBV infection]].


[[HBV]] carriers at high risk for [[HCC]] such as Asian men over 40 years and Asian women over 50 years of age, persons with [[cirrhosis]], family history of [[HCC]], Africans over 20 years of age and any carrier over 40 years, with persistent or intermittent [[ALT]] elevation and/or high [[HBV]] [[DNA]] level >2,000 IU/mL should be screened for [[hepatocellular carcinoma]].


==Screening==
==Screening==
Line 17: Line 18:
*Persons with multiple sexual partners or history of sexually transmitted disease
*Persons with multiple sexual partners or history of sexually transmitted disease
*Inmates of correctional facilities
*Inmates of correctional facilities
*Persons who have ever used injecting drugs, [[dialysis]] patients, [[HIV]] or [[HCV infected]] individuals, pregnant women, and family members, household members, and sexual contacts of [[HBV infected]] persons.  
*Persons who have ever used injecting drugs, [[dialysis]] patients, [[HIV]] or HCV infected individuals, pregnant women, and family members, household members, and sexual contacts of HBV infected persons.  
*Testing for [[HBsAg]] and [[anti-HBs]] should be performed, and [[seronegative]] persons should be vaccinated. ''(Grade I Recommendation)''}}
*Testing for [[HBsAg]] and anti-HBs should be performed, and [[seronegative]] persons should be vaccinated. ''(Grade I Recommendation)''}}


===Recommendations for HCC Screening: AASLD Practice Guidelines 2009===
===Recommendations for HCC Screening: AASLD Practice Guidelines 2009===
The following groups should be screened with US examination every 6-12 months: ''(Grade II-2)''<ref name="pmid15229781">{{cite journal |author=Lok AS, McMahon BJ |title=[AASLD Practice Guidelines. Chronic hepatitis B: update of therapeutic guidelines] |journal=[[Romanian Journal of Gastroenterology]] |volume=13 |issue=2 |pages=150–4 |year=2004 |month=June |pmid=15229781 |doi= |url=http://www.aasld.org/practiceguidelines/documents/bookmarked%20practice%20guidelines/chronic_hep_b_update_2009%208_24_2009.pdf |accessdate=2012-02-10}}</ref>
The following groups should be screened with US examination every 6-12 months: ''(Grade II-2)''<ref name="pmid15229781">{{cite journal |author=Lok AS, McMahon BJ |title=[AASLD Practice Guidelines. Chronic hepatitis B: update of therapeutic guidelines] |journal=[[Romanian Journal of Gastroenterology]] |volume=13 |issue=2 |pages=150–4 |year=2004 |month=June |pmid=15229781 |doi= |url=http://www.aasld.org/practiceguidelines/documents/bookmarked%20practice%20guidelines/chronic_hep_b_update_2009%208_24_2009.pdf |accessdate=2012-02-10}}</ref>
* [[HBV]] carriers at high risk for [[HCC]] such as Asian men over 40 years and Asian women over 50 years of age
* [[HBV]] carriers at high risk for [[HCC]] such as Asian men over 40 years and Asian women over 50 years of age

Revision as of 20:35, 29 July 2014

Hepatitis Main Page

Hepatitis B

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Hepatitis B from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Ultrasound

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hepatitis B screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hepatitis B screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hepatitis B screening

CDC on Hepatitis B screening

Hepatitis B screening in the news

Blogs on Hepatitis B screening

Directions to Hospitals Treating Hepatitis B

Risk calculators and risk factors for Hepatitis B screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]

Overview

High risk groups, such as : persons born in high or intermediate endemic areas; United States– born persons not vaccinated as infants whose parents were born in regions with high HBV endemicity; persons needing immunosuppressive therapy; patients with history of IV drugs history; among others, should be tested for HBV infection.

HBV carriers at high risk for HCC such as Asian men over 40 years and Asian women over 50 years of age, persons with cirrhosis, family history of HCC, Africans over 20 years of age and any carrier over 40 years, with persistent or intermittent ALT elevation and/or high HBV DNA level >2,000 IU/mL should be screened for hepatocellular carcinoma.

Screening

Recommendations for Persons Who Should Be Tested for HBV Infection: AASLD Practice Guidelines 2009

The following groups should be tested for HBV infection:[1]

  • Persons born in high or intermediate endemic areas
  • United States– born persons not vaccinated as infants whose parents were born in regions with high HBV endemicity]
  • Persons with chronically elevated aminotransferases
  • Persons needing immunosuppressive therapy
  • Men who have sex with men
  • Persons with multiple sexual partners or history of sexually transmitted disease
  • Inmates of correctional facilities
  • Persons who have ever used injecting drugs, dialysis patients, HIV or HCV infected individuals, pregnant women, and family members, household members, and sexual contacts of HBV infected persons.
  • Testing for HBsAg and anti-HBs should be performed, and seronegative persons should be vaccinated. (Grade I Recommendation)}}

Recommendations for HCC Screening: AASLD Practice Guidelines 2009

The following groups should be screened with US examination every 6-12 months: (Grade II-2)[1]

  • HBV carriers at high risk for HCC such as Asian men over 40 years and Asian women over 50 years of age
  • Persons with cirrhosis
  • Persons with a family history of HCC
  • Africans over 20 years of age
  • Any carrier over 40 years with persistent or intermittent ALT elevation and/or high HBV DNA level >2,000 IU/mL

For HBV carriers at high risk for HCC who are living in areas where US is not readily available, periodic screening with AFP should be considered. (Grade II-2)}}

References

  1. 1.0 1.1 Lok AS, McMahon BJ (2004). "[AASLD Practice Guidelines. Chronic hepatitis B: update of therapeutic guidelines]" (PDF). Romanian Journal of Gastroenterology. 13 (2): 150–4. PMID 15229781. Retrieved 2012-02-10. Unknown parameter |month= ignored (help)

Template:STD/STI

Template:WH Template:WS